Results 301 to 310 of about 36,032 (319)

Targeting Yezo Virus Structural Proteins for Multi-Epitope Vaccine Design Using Immunoinformatics Approach. [PDF]

Viruses
Rahman S, Rahman S, Chiou CC, Almutairi MM, Ajmal A, Batool S, Javed B, Tanaka T, Chen CC, Alouffi A, Ali A.   +10 more
europepmc   +1 more source

An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.

PLoS One
Sami MRS, Rani NA, Elahi MME, Hossain MS, Al Mueid MA, Rahim Z, Patil RB, Moin AT, Bithi IJ, Nahar S, Konika IJ, Roy S, Preya JA, Ahmed J.   +13 more
europepmc   +1 more source

Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection. [PDF]

Front Immunol
Fan Y, He Y, Li Y, Yin Z, Shi J, Tian T, Shang K, Shi H, Zhang F, Wen H.   +9 more
europepmc   +1 more source

Immunoinformatics design and synthesis of a multi-epitope vaccine against Helicobacter pylori based on lipid nanoparticles. [PDF]

Sci Rep
Jebali A, Esmaeilzadeh A, Esmaeilzadeh MK, Shabani S.   +3 more
europepmc   +1 more source

Designing a Candidate Multi-Epitope Vaccine against Transmissible Gastroenteritis Virus Based on Immunoinformatic and Molecular Dynamics. [PDF]

Int J Mol Sci
Bai Y, Zhou M, Wang N, Yang Y, Wang D.
europepmc   +1 more source

Design of a novel multi-epitope vaccine against Marburg virus using immunoinformatics studies. [PDF]

BMC Biotechnol
Al-Zayadi FQJ, Shakir AS, Kareem AS, Ghasemian A, Behmard E.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunoinformatics Protocol to Design Multi-Epitope Subunit Vaccines

2023
With the development of scientific technologies, the accessibility of genomic data, computational tools, software, databases, and machine learning, the field of immunoinformatics has emerged as an effective technique for immunologists to design potential vaccines in a short time.
Parismita, Kalita, Aditya K, Padhi, Timir, Tripathi   +2 more
openaire   +2 more sources

Design of multi-epitope, analogue-based cancer vaccines

Expert Opinion on Biological Therapy, 2003
The current objective of our cancer programme is to develop an effective vaccine based on rationally designed T cell epitope analogues, for use in the adjuvant setting for non-small cell lung cancer (NSCLC) and colon cancer. Analogue epitopes, enhanced for either human leukocyte antigen (HLA) binding or T cell receptor (TCR) signalling, have been shown
John Fikes, Alessandro Sette
openaire   +3 more sources